Maharashtra Bans Analogue Paneer for 1 Year; Violators May Face ₹10 Lakh Fine

The Maharashtra government has imposed a 1-year ban on the manufacture and sale of analogue paneer across the state, according to a PTI report. The decision follows concerns over food safety compliance and allegations that some food businesses were selling analogue paneer as conventional dairy paneer without disclosure.

According to officials, the move comes after a year-long enforcement drive conducted by the Food and Drug Administration (FDA). The restriction took effect through a gazette notification issued by Maharashtra Food Safety Commissioner Tukaram Mundhe.

Maharashtra Analogue Paneer Ban Notification

The notification prohibits the manufacturing, processing, preparation, packing, storage, distribution, wholesale sale, retail sale and offering for sale of analogue paneer across Maharashtra. Analogue paneer is a non-dairy substitute made using vegetable oils, starches, emulsifiers and other additives instead of milk fat.

It is generally cheaper to produce than conventional dairy paneer and typically contains lower protein levels. Officials said the order has been issued under provisions of the Food Safety and Standards Act and can remain in force for a maximum period of 1 year.

Why Maharashtra Banned Analogue Paneer?

The FDA said inspections revealed that several hotels, restaurants, caterers and food establishments were using analogue paneer in place of conventional paneer without informing consumers. Authorities found that substitutions were often not disclosed on menus, invoices or display boards.

According to the FDA, such practices can mislead consumers regarding the nature of the food being served. The agency stated that continued violations and inadequate compliance prompted the decision to impose the temporary ban.

Maharashtra FDA Findings on Food Safety Violations

The order follows a year-long surveillance and enforcement campaign carried out by the FDA across the state. During the drive, 35.4% of analysed samples failed to conform to prescribed standards, indicating significant compliance issues.

Officials noted that routine inspections, sampling exercises and awareness programmes did not adequately curb the sale of analogue paneer. The findings led authorities to conclude that stronger regulatory action was required to address consumer protection concerns.

Penalties for Selling Analogue Paneer in Maharashtra

The FDA has warned that serving analogue paneer as conventional dairy paneer without proper disclosure could be treated as an unfair trade practice under the Food Safety and Standards Act. Depending on the severity of the violation and the harm caused, penalties can vary substantially.

Offenders may face imprisonment ranging from 6 months with a fine of ₹1 lakh to life imprisonment with a minimum fine of ₹10 lakh in cases where unsafe food consumption results in death. Authorities also highlighted that analogue paneer was frequently transported and sold without original packaging, mandatory labels, invoices, batch identification or traceability records, making enforcement more difficult.

Read More: Maharashtra Land Titling Law to Introduce Digital Property Cards for Owners.

For daily market updates and regular stock market news in Hindi, stay tuned to Angel One's share market news in Hindi.

Conclusion

The Maharashtra government's decision introduces a statewide 1-year prohibition on analogue paneer amid concerns over food safety and consumer transparency. Authorities cited widespread violations, misleading sales practices and a high proportion of non-compliant samples as key reasons for the action.

The FDA has also emphasised strict penalties for businesses that fail to comply with food safety regulations or misrepresent food products. The development represents a significant regulatory measure aimed at strengthening food labelling compliance and consumer awareness across the state.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.